A phase 1, first-in-human study of AMT-676, an anti-CDH17 antibody-drug conjugate, in patients with advanced gastrointestinal tumors.

Authors: Charlotte Rose Lemech, Warren Lance Joubert, Andrew Ohyama Parsonson, Rui-Hua Xu, Rajiv Shinde, Prachi Bhave, Junli Xue, Yaling Huang, Xun Meng, Shu-Hui Liu

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3161

Source: Full article

---

Abstract

TPS3161